UV Spectroscopic Analysis of Recombinant Protein Drugs

Recombinant protein drugs refer to protein products sourced from animals and plants and developed through biotechnology research. These products possess certain biological activities and can prevent, treat, and diagnose diseases in humans, animals, and plants. Compared with small molecule drugs, recombinant protein drugs have advantages such as high activity, high specificity, and low toxicity, making them favored by many researchers. At present, recombinant protein drugs have been widely used in various fields such as tumors, autoimmune diseases, metabolic diseases, aging diseases, and degenerative diseases. Recombinant protein drugs are a type of large molecule complex compound, and understanding their structure is crucial for understanding their function and stability.

 

Spectroscopic technology is widely used to study the secondary structure of proteins, such as ultraviolet spectroscopy. The biggest advantage of this technology is that it is time-efficient, allowing for quick acquisition of relevant information. Ultraviolet spectroscopy can obtain information about molecular structure and functional groups, which is extremely important for the development of recombinant protein drugs. In addition, ultraviolet spectroscopy can also be used to study the structure, stability, and folding state of recombinant protein drugs. By measuring their absorption spectra in the ultraviolet light region, information about their secondary and tertiary structures can be obtained.

 

MtoZ Biolabs provides a one-stop UV spectroscopy analysis service for recombinant protein drugs, which is suitable for the analysis of substances with conjugated systems or specific functional groups.